Arcellx to participate in two upcoming investor conferences

Redwood city, calif. , oct. 26, 2023 /prnewswire/ -- arcellx, inc. (nasdaq: aclx), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that the management team will participate in two upcoming investor conferences: td cowen 7th annual fall oncology innovation summit (virtual) fireside chat: friday, november 3 at 12:30 p.m.
ACLX Ratings Summary
ACLX Quant Ranking